Please use this identifier to cite or link to this item: https://swslhd.intersearch.com.au/swslhdjspui/handle/1/13152
Full metadata record
DC FieldValueLanguage
dc.contributor.authorYap, N.-
dc.contributor.authorWong, V.-
dc.contributor.authorMorton, C.-
dc.contributor.authorde Boer, R.-
dc.contributor.authorBaron-Hay, S.-
dc.contributor.authorBlum, R.-
dc.contributor.authorForster, B.-
dc.contributor.authorChua, S.-
dc.contributor.authorClarke, K.-
dc.contributor.authorCuff, K.-
dc.contributor.authorGreen, M.-
dc.contributor.authorLim, E.-
dc.contributor.authorMok, K.-
dc.contributor.authorNott, L.-
dc.contributor.authorNottage, M.-
dc.contributor.authorTafreshi, A.-
dc.contributor.authorTsoi, D.-
dc.contributor.authorUccellini, A.-
dc.contributor.authorGibbs, P.-
dc.contributor.authorLok, S. W.-
dc.date.accessioned2024-12-11T00:34:25Z-
dc.date.available2024-12-11T00:34:25Z-
dc.date.issued2024-
dc.identifier.issn14440903 (ISSN)-
dc.identifier.urihttps://swslhd.intersearch.com.au/swslhdjspui/handle/1/13152-
dc.description.abstractThis study evaluated patient-reported outcomes (PROs) of Medicine Access Programmes (MAPs) for Australian metastatic breast cancer patients on ribociclib. Limited patient awareness of MAP enrolment was identified, emphasising the need for improved education and consent processes. Most patients expressed gratitude for accessing non-funded medications and perceived enhanced medication adherence as a key benefit. Integrating PRO data with real-world registry data provides comprehensive insight for future MAP development. � 2024 Royal Australasian College of Physicians.-
dc.publisherJohn Wiley and Sons Inc-
dc.subjectMedication Access Programme patient-reported outcome quality of life Adult Aged Aminopyridines Antineoplastic Agents Australia Breast Neoplasms Female Health Services Accessibility Humans Medication Adherence Middle Aged Neoplasm Metastasis Patient Reported Outcome Measures Purines aminopyridine derivative antineoplastic agent purine derivative ribociclib breast tumor drug therapy health care access human medication compliance metastasis pathology-
dc.titleMedicine Access Programmes: what do patients think ? a patient-reported outcome study on ribociclib in metastatic breast cancer in Australia-
dc.typeJournal Article-
dc.description.affiliatesDepartment of General Medicine, Royal Melbourne Hospital, Melbourne, VIC, Australia Gibbs Labs, Personalised Oncology Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia Department of Medical Oncology, Western Health, Melbourne, VIC, Australia Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia St Vincent's Private Hospital, Melbourne, VIC, Australia Department of Medical Oncology, Northern Cancer Institute, Sydney, NSW, Australia Department of Medical Oncology, Bendigo Health, Bendigo, VIC, Australia Department of Medical Oncology, Mater Hospital, Sydney, NSW, Australia Department of Medical Oncology, Eastern Health, Melbourne, VIC, Australia Department of Medical Oncology, Albury Wodonga Regional Cancer Centre, Albury, NSW, Australia Department of Medical Oncology, Princess Alexandra Hospital, Brisbane, QLD, Australia Epworth Freemasons, Melbourne, VIC, Australia Department of Medical Oncology, Kinghorn Cancer Centre, Sydney, NSW, Australia Department of Medical Oncology, Liverpool Hospital, Sydney, NSW, Australia Department of Medical Oncology, Royal Hobart Hospital, Hobart, TAS, Australia Department of Medical Oncology, Royal Brisbane Hospital, Brisbane, QLD, Australia Department of Medical Oncology, Wollongong Private Hospital, Wollongong, NSW, Australia Department of Medical Oncology, St John of God Hospital, Perth, WA, Australia Olivia Newton-John Cancer and Wellness Centre, Austin Health, Melbourne, VIC, Australia-
dc.identifier.doi10.1111/imj.16536-
dc.type.studyortrialArticle-
dc.identifier.journaltitleInternal Medicine Journal-
Appears in Collections:Liverpool Hospital

Files in This Item:
There are no files associated with this item.


Items in Prosentient are protected by copyright, with all rights reserved, unless otherwise indicated.

Google Media

Google ScholarTM

Who's citing